 Tomoko Matsuo
Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipoproteins, LDL | 4 | 2006 | 124 | 0.390 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2006 | 138 | 0.310 |
Why?
| | Prostaglandin D2 | 1 | 2004 | 20 | 0.230 |
Why?
| | Surgical Staplers | 2 | 2013 | 4 | 0.210 |
Why?
| | Anastomosis, Surgical | 2 | 2013 | 131 | 0.200 |
Why?
| | Macrophages | 2 | 2004 | 1233 | 0.180 |
Why?
| | Candidiasis, Cutaneous | 1 | 2020 | 2 | 0.170 |
Why?
| | Diaper Rash | 1 | 2020 | 4 | 0.170 |
Why?
| | Candidiasis, Vulvovaginal | 1 | 2020 | 4 | 0.170 |
Why?
| | NF-kappa B | 1 | 2004 | 615 | 0.170 |
Why?
| | Soaps | 1 | 2020 | 10 | 0.170 |
Why?
| | Tachykinins | 1 | 2019 | 7 | 0.170 |
Why?
| | Skin Care | 1 | 2020 | 18 | 0.170 |
Why?
| | Pruritus | 1 | 2019 | 58 | 0.170 |
Why?
| | Antifungal Agents | 1 | 2020 | 125 | 0.160 |
Why?
| | Ergonomics | 2 | 2013 | 22 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2019 | 652 | 0.130 |
Why?
| | Macrophages, Peritoneal | 2 | 2006 | 88 | 0.120 |
Why?
| | Physicians | 2 | 2013 | 765 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2006 | 2164 | 0.110 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 244 | 0.110 |
Why?
| | Surgical Stapling | 1 | 2013 | 9 | 0.110 |
Why?
| | Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 42 | 0.100 |
Why?
| | Pyrazines | 1 | 2013 | 70 | 0.100 |
Why?
| | Hand Strength | 1 | 2013 | 95 | 0.100 |
Why?
| | Triazoles | 1 | 2013 | 123 | 0.100 |
Why?
| | Consumer Behavior | 1 | 2012 | 65 | 0.100 |
Why?
| | Gastroenterology | 1 | 2012 | 159 | 0.090 |
Why?
| | Mice, Inbred C3H | 3 | 2006 | 242 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 144 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 2 | 2006 | 163 | 0.070 |
Why?
| | Chromans | 1 | 2006 | 21 | 0.070 |
Why?
| | Attitude of Health Personnel | 1 | 2012 | 970 | 0.060 |
Why?
| | Thiazolidinediones | 1 | 2006 | 134 | 0.060 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2004 | 72 | 0.060 |
Why?
| | Blood Glucose | 1 | 2013 | 1823 | 0.060 |
Why?
| | Cyclopentanes | 1 | 2004 | 13 | 0.060 |
Why?
| | Thymidine | 1 | 2004 | 57 | 0.060 |
Why?
| | Glomerular Mesangium | 1 | 2003 | 17 | 0.060 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2004 | 72 | 0.060 |
Why?
| | Luciferases | 1 | 2004 | 139 | 0.050 |
Why?
| | Hypoglycemic Agents | 2 | 2013 | 1006 | 0.050 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 57 | 0.050 |
Why?
| | Deoxyguanosine | 1 | 2003 | 26 | 0.050 |
Why?
| | Japan | 2 | 2013 | 85 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2004 | 1110 | 0.050 |
Why?
| | Isoenzymes | 1 | 2003 | 273 | 0.050 |
Why?
| | Physicians, Women | 2 | 2013 | 55 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 745 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2004 | 331 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 842 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 516 | 0.050 |
Why?
| | Diabetic Angiopathies | 1 | 2003 | 246 | 0.050 |
Why?
| | Male | 9 | 2020 | 55112 | 0.050 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 371 | 0.040 |
Why?
| | Diapers, Adult | 1 | 2020 | 1 | 0.040 |
Why?
| | Miconazole | 1 | 2020 | 4 | 0.040 |
Why?
| | Base Sequence | 1 | 2004 | 2080 | 0.040 |
Why?
| | Candida | 1 | 2020 | 32 | 0.040 |
Why?
| | Histamine | 1 | 2019 | 56 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 76 | 0.040 |
Why?
| | Injections, Spinal | 1 | 2019 | 101 | 0.040 |
Why?
| | Chloroquine | 1 | 2019 | 51 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2019 | 1822 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2020 | 56 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1397 | 0.040 |
Why?
| | Cell Line | 1 | 2004 | 2581 | 0.040 |
Why?
| | Mitochondria | 1 | 2003 | 735 | 0.040 |
Why?
| | DNA | 1 | 2004 | 1331 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2019 | 446 | 0.030 |
Why?
| | Mice | 4 | 2006 | 14679 | 0.030 |
Why?
| | Animals | 5 | 2019 | 31162 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2013 | 2088 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2139 | 0.030 |
Why?
| | Sitagliptin Phosphate | 1 | 2013 | 29 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2013 | 43 | 0.030 |
Why?
| | Gloves, Surgical | 1 | 2012 | 3 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2530 | 0.020 |
Why?
| | Humans | 8 | 2020 | 113531 | 0.020 |
Why?
| | Aged | 3 | 2020 | 18944 | 0.020 |
Why?
| | Middle Aged | 4 | 2013 | 26552 | 0.020 |
Why?
| | Female | 5 | 2020 | 59115 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 541 | 0.020 |
Why?
| | Insulin | 2 | 2013 | 2076 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 6296 | 0.020 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2013 | 505 | 0.020 |
Why?
| | Hypoglycemia | 1 | 2013 | 386 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 6189 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9006 | 0.020 |
Why?
| | Body Mass Index | 1 | 2013 | 1952 | 0.020 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2004 | 5 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2012 | 940 | 0.010 |
Why?
| | Simvastatin | 1 | 2004 | 58 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2004 | 81 | 0.010 |
Why?
| | Lipid Peroxidation | 1 | 2004 | 138 | 0.010 |
Why?
| | Thenoyltrifluoroacetone | 1 | 2003 | 1 | 0.010 |
Why?
| | Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2003 | 4 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2003 | 15 | 0.010 |
Why?
| | Ionophores | 1 | 2003 | 21 | 0.010 |
Why?
| | Cyclooxygenase 1 | 1 | 2003 | 20 | 0.010 |
Why?
| | Chelating Agents | 1 | 2003 | 60 | 0.010 |
Why?
| | Tunica Media | 1 | 2003 | 35 | 0.010 |
Why?
| | Ion Channels | 1 | 2003 | 121 | 0.010 |
Why?
| | Carotid Artery, Common | 1 | 2003 | 29 | 0.010 |
Why?
| | Tunica Intima | 1 | 2003 | 78 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 2003 | 161 | 0.010 |
Why?
| | Diabetic Neuropathies | 1 | 2003 | 78 | 0.010 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2003 | 158 | 0.010 |
Why?
| | Albuminuria | 1 | 2003 | 164 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2004 | 337 | 0.010 |
Why?
| | Signal Transduction | 2 | 2004 | 4439 | 0.010 |
Why?
| | Adult | 2 | 2013 | 30245 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 2003 | 302 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2003 | 212 | 0.010 |
Why?
| | Pyridines | 1 | 2004 | 417 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 912 | 0.010 |
Why?
| | Creatinine | 1 | 2003 | 434 | 0.010 |
Why?
| | Diabetic Retinopathy | 1 | 2003 | 148 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2003 | 712 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 4593 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 685 | 0.010 |
Why?
| | Glucose | 1 | 2003 | 894 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2003 | 1008 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2507 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 3802 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2444 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 3389 | 0.010 |
Why?
| | Risk Factors | 1 | 2003 | 8606 | 0.010 |
Why?
|
|
Matsuo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|